On February 6, Dechert is proud to host the 2024 Life Sciences Day, an interdisciplinary program designed for in-house counsel, chief officers, and strategic buyers. This dynamic half-day occasion will characteristic knowledgeable panels discussing key points within the life sciences sector and embrace audio system from main pharmaceutical and biotech firms.  

Our panelists will information you thru the life sciences panorama, from product improvement to post-launch litigation. You’ll have the chance to listen to from business insiders on rising authorized, regulatory, and enterprise challenges, in addition to efficient danger mitigation methods. Click on right here to register.

The matters we’ll cowl embrace:

·        Cybersecurity and privateness dangers to life sciences firms, together with the affect of AI on the risk panorama

·        Current developments in complicated and securities litigation towards U.S. life sciences firms

·        Key concerns for an efficient M&A technique

·        How scientific proof can win a product legal responsibility case

·        Methods for managing a number of litigation fronts when you go to market

As well as, we’re excited to host a fireplace chat with Sir Gregory Paul Winter, a Nobel-Prize successful molecular biologist. Sir Winter’s groundbreaking work has revolutionized the sector of drugs paving the best way for the event of quite a few transformative, life-saving therapies, and has been cited by many courts in complicated life sciences circumstances, together with the U.S. Supreme Courtroom in a 2023 seminal patent case.

Occasion Particulars:

Location: CYTO | PHL, Cira Centre, 2929 Arch Road, Philadelphia, PA 19104

Date: Tuesday, February 6, 2024

11:45 a.m. – Registration

12:15 p.m. – Program

5:00 p.m. – Networking reception

Be part of us for an enlightening day of debate and networking. We look ahead to seeing you there!

CLE Info:

Functions for accreditation of this program for Persevering with Authorized Schooling in Massachusetts, New Jersey, New York, and Pennsylvania are presently pending.